InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: None

Thursday, 05/14/2020 6:26:46 PM

Thursday, May 14, 2020 6:26:46 PM

Post# of 426487
USPTO Amicus Briefs....see the link below

https://foiadocuments.uspto.gov/amicus/

Ideally it would be great if the FDA submitted an amicus brief but they would likely remain agnostic. The FDA submission of a brief (wishful thinking) would be huge. There is a public health implication here if AMRN decides not to advertise / educate the marketplace but FDA may choose to remain on sidelines. Perhaps the USPTO will submit a brief.

This litigation overhang on the stock price is real. SMH

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News